Care Bare Rx vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Care Bare Rx scores higher on our rubric, 7.4/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

Care Bare Rx beats MEDVi overall, scoring 7.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Care Bare Rx is from $199/mo; MEDVi is $179 first month, then $299/mo. Choose Care Bare Rx for users who prefer oral glp-1 pills and want a simple, no-appointment process. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at Care Bare Rx and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Care Bare Rx

#26 of 54

7.4/10

Simple GLP-1 provider offering oral pill options with a streamlined no-appointment-needed process.

Visit Care Bare Rx

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	Care Bare Rx	MEDVi
Why each one	Both oral pill and injectable GLP-1 options at the same flat $199/mo rate, backed by named physician leadership.	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	7.4/10	5.7/10
Headline Price	from $199/mo	$179 first month, then $299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who prefer oral GLP-1 pills and want a simple, no-appointment process	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#26	#46
Get started	Visit Care Bare Rx	Visit MEDVi

Pros & Cons Compared

Care Bare Rx

Pros

+Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate, flexibility to switch formats
+Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
+Same price at every dose with no hidden fees, simple, transparent billing
+Free shipping included on all orders

Cons

−Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.
−Independent reviews are still very limited, so satisfaction and reliability are hard to verify. The named physician leadership is the main trust signal to weigh.
−Cash-pay only: no insurance accepted, and HSA/FSA eligibility isn't disclosed. Budget the $199/mo as a full out-of-pocket cost.

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Care Bare Rx edges out MEDVi with a score of 7.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Care Bare Rx is from $199/mo; MEDVi is $179 first month, then $299/mo.